
- This event has passed.
Devices and Diagnostics – R&D strategy in Diagnostic Blood & Plasma Screening Technology
November 3, 2020 @ 2:00 pm – 2:30 pm
Speakers: Christophe Van der Linden, Senior Business Consultant & Jasper Van de Sande, Business Consultant, suAzio
Convenor: Bernadette Rogers, General Manager EphMRA
Description: Devices and Diagnostics – R&D strategy in Diagnostic Blood & Plasma Screening Technology
This paper will discuss how to set R&D priorities for the launch of a new product in diagnostic nucleic acid testing (NAT). The speakers will review current products in the market, including key features and performance attributes. With these attributes they will discuss how to set up an adaptive choice based conjoint methodology to evaluate the most attractive product configuration and simulate optimal price settings.
During this paper suAzio will discuss 1) the benefits of Adaptive Choice Based Conjoint compared to traditional Choice Based Conjoint, 2) how to apply conjoint in Diagnostics and 3) strategic scenario’s for product configuration
You will go away with the following key takeaways:
- Adaptive Choice Based Conjoint is a preferred conjoint methodology
- Understanding the trade off in diagnostics technology features will support R&D strategy

Christophe Van der Linden, Senior Business Consultant
suAzio
Christophe is the founder and CEO of suAzio consulting . He holds a Master’s degree in Commercial Engineering from the University of Limburg, an MBA from Vlerick University, and has over 20 years of experience in market research and marketing consulting in Medical Technology markets. Christophe’s consultancy and strategic market research competencies span a variety of topics within the life sciences industry and technology markets

Jasper Van de Sande
suAzio
Jasper joined suAzio Consulting in 2018. He holds a master’s degree in Social Psychology from University of Tilburg. Jasper has 15+ years of experience in international market intelligence in different pharmaceutical and medical device companies (JNJ, Medtronic).
His primary interest is in consumer behavior, behavioral economics and new business development. Using his years of business consultancy experience, he is always looking for the best way to generate insight and will embrace innovation.